Book Consultation

What is Macular Degeneration (AMD)?

Macular degeneration is a leading cause of central vision loss, particularly in older adults. It affects the macula—the area of the retina responsible for sharp, detailed vision—making everyday tasks, such as reading or recognising faces, challenging.

retina

Symptoms of Macular Degeneration

  • Blurred or distorted central vision
  • Difficulty reading or recognising faces
  • Straight lines appearing wavy

Dry Age-Related Macular Degeneration (Dry AMD)

Dry AMD is the most common form of macular degeneration, characterised by a gradual deterioration of the macula. It progresses slowly, leading to a gradual loss of central vision over time. Although it does not involve abnormal blood vessel growth, lifestyle modifications and nutritional supplements may help slow its progression.

Important: Dry AMD can eventually convert to wet AMD, which requires urgent treatment.

Dry Age-Related Macular Degeneration (Dry AMD)

From Dry to Wet AMD: Understanding Progression and Treatment 

The key difference between dry and wet AMD lies in their progression and treatment. Dry AMD is managed with lifestyle changes and nutritional supplements, whereas wet AMD involves the rapid growth of abnormal blood vessels that cause sudden vision loss. Dry AMD can progress to Wet AMD, which can cause more rapid and severe sight loss.

Because early detection can mean the difference between preserved vision and rapid decline, it’s crucial to monitor any changes closely. While many clinics rely solely on standard OCT scans—which detect fluid leakage—OCT‐Angiography (OCT‐A) actually visualises the blood vessels from which the fluid leaks, enabling a more precise diagnosis and earlier intervention in wet AMD.

Dry to Wet AMD

Why OCT-A is Essential for Diagnosing Wet AMD

Early detection is critical for treating wet AMD. Standard OCT scans only detect fluid leakage, but OCT‐Angiography (OCT‐A) directly visualises the abnormal blood vessels called choroidal neovascularisation (CNV) responsible for the leakage. This breakthrough technology enables:

  • Faster, more accurate treatment decisions
  • No need for invasive dye injections (FFA)
  • Earlier detection of disease progression

OCT-A vs. FFA: A Quick Comparison

Feature OCT-A FFA (Fluorescein Angiography)
Invasiveness Non-invasive Invasive (requires dye injection)
Detection Accuracy Direct visualisation of CNV Indirect detection via fluid leakage
Procedure Time Quick (5–10 minutes) Longer (30+ minutes)
Side Effects None Possible nausea, allergic reactions

OCT-A is an integral part of our diagnostic process that enables early intervention in wet AMD.

Treatment for Wet AMD

For patients diagnosed with wet AMD, the gold standard is intravitreal injections. Medications such as Eylea or Vabysmo are injected directly into the eye to reduce fluid build-up and abnormal vessel growth, thereby preserving your vision.

BEFORE Wet AMD before treatment
AFTER Wet AMD after treatment

Retinal Vein Occlusion: Diagnosis and Treatment

Retinal vein occlusion (RVO) occurs when a vein in the retina becomes blocked, causing fluid accumulation and swelling that can lead to sudden vision loss—often in one eye.

Symptoms of Retinal Vein Occlusion

  • Blurry or dark spots in vision
  • Sudden loss of vision in one eye
  • Distorted or wavy sight

Types of RVO

  • Branch Retinal Vein Occlusion (BRVO):
    Affects only a segment of the retina due to a blockage in a branch retinal vein.
  • Central Retinal Vein Occlusion (CRVO):
    Affects the entire retina due to a blockage in the central retinal vein.

Treatment for RVO with Macular Oedema

Intravitreal injections using Eylea or Vabysmo or Ozurdex help reduce swelling and prevent further damage, stabilising your vision over time.

Symptoms of Retinal Vein Occlusion

Diabetic Retinopathy and Its Impact

Diabetic retinopathy is a complication of diabetes that damages the retinal blood vessels, potentially leading to permanent vision loss if untreated.

Symptoms of Diabetic Retinopathy

  • Blurred or fluctuating vision
  • Dark spots or floaters
  • Difficulty seeing at night

Treatment for Diabetic Retinopathy

At DS Eye Surgeon, we use OCT and OCT-A to assess the severity of diabetic retinopathy and monitor its progression. Intravitreal injections are the gold standard for preventing further vision loss in advanced cases.

Diabetic Retinopathy

Intravitreal Injections: The Gold Standard Treatment

Intravitreal injections are the cornerstone of managing retinal conditions. By delivering medication directly into the eye, these injections help reduce inflammation, control abnormal vessel growth, and prevent further vision deterioration.

Types of Intravitreal Injections We Offer

Eylea & Vabysmo
Ideal for wet AMD, retinal vein occlusion, and diabetic retinopathy. Typically administered during an initial loading phase of 3–4 monthly injections, then every 8–12 weeks.

Ozurdex
A slow-release steroid implant used for diabetic retinopathy and RVO, effective for 4–6 months per dose.

Treatment Fees

  • Eylea Injection – £1,500 per injection
  • Vabysmo Injection – £1,500 per injection
  • Ozurdex Implant – £2,500 per implant

Advanced Cataract Surgery with Retinal Treatment

For patients with both cataracts and a retinal condition (such as wet AMD, diabetic maculopathy, or RVO), we offer a combined procedure. This approach removes the cataract and administers an intravitreal injection during the same surgery, resulting in:

  • Fewer surgical visits
  • Faster overall recovery
  • Optimised vision outcomes

Cataract removal sharpens vision while the injection stabilises the retina.

Your Patient Journey: From Consultation to Care

We believe that clear communication and compassionate care are the cornerstones of successful treatment. Here’s what you can expect when you choose DS Eye Surgeon:

1
Consultation & Diagnosis
A comprehensive eye exam using OCT and OCT-A imaging.
2
Personalised Treatment Plan
A detailed discussion about your condition and the best treatment approach.
3
Intravitreal Injections or Combined Procedures
Quick, virtually painless procedures performed in a modern, safe environment.
4
Ongoing Monitoring
Regular follow-ups using OCT and OCT-A to track progress and adjust treatment as needed.

Frequently Asked Questions